Prevalence and Type Distribution of Human Papillomavirus (HPV) in Malaysian Women with and Without Cervical Cancer: an Updated Estimate

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2018 Mar 1

PMID 29487170

Citations 11

Authors

Shing Cheng Tan

Mohd Pazudin Ismail

Daniel Roza Duski

Nor Hayati Othman

Ravindran Ankathil

Affiliations

Soon will be listed here.

Abstract

Information on the prevalence and type distribution of human papillomavirus (HPV) among Malaysian women is currently limited. The present study therefore aimed to provide an updated estimate on the prevalence and type distribution of HPV among Malaysian women with and without cervical cancer. Total DNA was isolated from the cervical cell specimens of 185 histopathologically confirmed cervical cancer patients and 209 cancer-free healthy females who were tested negative in a recent Pap test. Viral-specific DNA was subsequently amplified with biotinylated primers and hybridized to HPV type-specific probes via a proprietary "flow-through hybridization" process for determination of HPV genotype. It was demonstrated that 83.2% of the cervical cancer patients and none (0.0%) of the cancer-free females were positive for HPV infection. Among HPV-positive subjects, 14 different viral genotypes were observed, namely HPV16, 18, 31, 33, 35, 45, 52, 53, 58, 66/68, 73, 81, 82, and 84/26. A total of 91.6% of the HPV-positive subjects had single-type HPV infections and the remaining 8.4% were simultaneously infected by two HPV genotypes. The most common HPV infections found were HPV16 (35.7%), HPV18 (26.0%), HPV58 (9.1%), and HPV33 (7.1%) single-type infections, followed by HPV16 + HPV18 co-infections (5.2%). The study has successfully provided an updated estimate on the prevalence and type distribution of HPV among Malaysian women with and without cervical cancer. These findings could contribute valuable information for appraisal of the impact and cost-effectiveness of prophylactic HPV vaccines in the Malaysian population.

Citing Articles

Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.

Hashemi M, Khosroshahi E, Daneii P, Hassanpoor A, Eslami M, Koohpar Z Noncoding RNA Res. 2024; 10:98-115.

PMID: 39351450 PMC: 11440256. DOI: 10.1016/j.ncrna.2024.09.006.

Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.

Jain M, Yadav D, Jarouliya U, Chavda V, Yadav A, Chaurasia B Pathogens. 2023; 12(12).

PMID: 38133265 PMC: 10745624. DOI: 10.3390/pathogens12121380.

Associations of multi-human papillomavirus infections with expression of p16 in a cohort of women who underwent colposcopy: a retrospective study of 5165 patients.

Zhang Y, Li H, Li X, Li Z, You Q, Liu H Front Oncol. 2023; 13:1265726.

PMID: 37965476 PMC: 10641385. DOI: 10.3389/fonc.2023.1265726.

Associations of human papillomavirus genotypes and cervical vascular abnormality in a cohort of women underwent colposcopy, a retrospective study of 6716 patients.

Zhang Y, Li H, Li X, Li Z, You Q, Yi H Front Oncol. 2023; 13:1105482.

PMID: 37091162 PMC: 10113430. DOI: 10.3389/fonc.2023.1105482.

Detection and Genotyping of Human Papillomavirus (HPV16/18), Epstein-Barr Virus (EBV), and Human Cytomegalovirus (HCMV) in Endometrial Endometroid and Ovarian Cancers.

Grabarek B, Ossowski P, Czarniecka J, Ozog M, Prucnal J, Dziuba I Pathogens. 2023; 12(3).

PMID: 36986319 PMC: 10053580. DOI: 10.3390/pathogens12030397.

References

Plummer M, Peto J, Franceschi S . Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer. 2011; 130(11):2638-44. PMC: 3982220. DOI: 10.1002/ijc.26250. View

Wang L, Wu B, Li J, Chen L . Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer patients in Hunan province, central south China. J Med Virol. 2015; 87(3):516-21. DOI: 10.1002/jmv.24094. View

Clifford G, Franceschi S, Diaz M, Munoz N, Villa L . Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006; 24 Suppl 3:S3/26-34. DOI: 10.1016/j.vaccine.2006.05.026. View

Yadav M, Nurhayati Z, Padmanathan A, Abdul Aziz Y, Norhanom A . Polymerase chain reaction detection and restriction enzyme typing of human papillomavirus in cervical carcinoma. Med J Malaysia. 1995; 50(1):64-71. View

Abreu A, Souza R, Gimenes F, Consolaro M . A review of methods for detect human Papillomavirus infection. Virol J. 2012; 9:262. PMC: 3507852. DOI: 10.1186/1743-422X-9-262. View

Li Z, Liu F, Cheng S, Shi L, Yan Z, Yang J . Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China. Sci Rep. 2016; 6:21039. PMC: 4751528. DOI: 10.1038/srep21039. View

Othman N, Othman N . Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation. Asian Pac J Cancer Prev. 2014; 15(5):2245-9. DOI: 10.7314/apjcp.2014.15.5.2245. View

Sharifah N, Seeni A, Nurismah M, Clarence-Ko C, Hatta A, Ho N . Prevalence of human papillomavirus in abnormal cervical smears in Malaysian patients. Asian Pac J Cancer Prev. 2009; 10(2):303-6. View

Lee E, Um T, Chi H, Hong Y, Cha Y . Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay. J Korean Med Sci. 2012; 27(9):1091-7. PMC: 3429829. DOI: 10.3346/jkms.2012.27.9.1091. View

10.

Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G . Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer. 2010; 103(2):209-16. PMC: 2906740. DOI: 10.1038/sj.bjc.6605747. View

11.

Franceschi S, Herrero R, Clifford G, Snijders P, Arslan A, Anh P . Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006; 119(11):2677-84. DOI: 10.1002/ijc.22241. View

12.

Tay S, Tay Y . The prevalence and significance of high-risk human papillomavirus DNA test in southern Malaysia and Singapore. Aust N Z J Obstet Gynaecol. 2009; 49(3):323-7. DOI: 10.1111/j.1479-828X.2009.01000.x. View

13.

Baloch Z, Li Y, Yuan T, Feng Y, Liu Y, Tai W . Epidemiologic characterization of human papillomavirus (HPV) infection in various regions of Yunnan Province of China. BMC Infect Dis. 2016; 16:228. PMC: 4881205. DOI: 10.1186/s12879-016-1562-7. View

14.

Raub S, Isa N, Zailani H, Omar B, Abdullah M, Mohd Amin W . Distribution of HPV genotypes in cervical cancer in multi- ethnic Malaysia. Asian Pac J Cancer Prev. 2014; 15(2):651-6. DOI: 10.7314/apjcp.2014.15.2.651. View

15.

Schiffman M, Wentzensen N . Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013; 22(4):553-60. PMC: 3711590. DOI: 10.1158/1055-9965.EPI-12-1406. View

16.

Wong O, Lo C, Chow J, Tsun O, Szeto E, Liu S . Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population. J Clin Microbiol. 2012; 50(5):1691-7. PMC: 3347143. DOI: 10.1128/JCM.05933-11. View

17.

Tjalma W, Depuydt C . Cervical atypical glandular cells and false negative HPV testing: a dramatic reality of the wrong test at the right place. Eur J Gynaecol Oncol. 2014; 35(2):117-20. View

18.

Chan P, Chang A, Yu M, Li W, Chan M, Yeung A . Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer. 2009; 126(1):297-301. DOI: 10.1002/ijc.24731. View

19.

Bernard H, Burk R, Chen Z, Van Doorslaer K, Zur Hausen H, de Villiers E . Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010; 401(1):70-9. PMC: 3400342. DOI: 10.1016/j.virol.2010.02.002. View

20.

Westra W . Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014; 50(9):771-9. PMC: 4318232. DOI: 10.1016/j.oraloncology.2014.05.004. View